Texas Capital Bank Wealth Management Services Inc
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1802655
Dallas, TX
Position in REGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$237,973
-$6,709 QoQ
Shares Held
308
-2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 17.857142857142858.ToString("F0")%
Shared 82.14285714285714.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Texas Capital Bank Wealth Management Services Inc holds $1,475,801 across 7 Biotechnology names. REGN ranks #4 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IRD |
Opus Genetics, Inc.
|
88,500 | $402,675 | |
| 2 | RNTX |
Rein Therapeutics, Inc.
|
273,625 | $355,712 | |
| 3 | ACTU |
Actuate Therapeutics, Inc.
|
94,592 | $259,181 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
308 | $237,973 | |
| 5 | CGTX |
Cognition Therapeutics Inc
|
123,296 | $93,704 | |
| 6 | CUE |
Cue Biopharma, Inc.
|
397,421 | $91,406 | |
| 7 | INAB |
In8bio, Inc.
|
23,750 | $35,150 |
All Filings in REGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $237,973 | 308 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $244,682 | 317 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||